QIAGEN NV EO -,01 | 44.180 / +0.94% |
Date/Time | 01/18 / 22:46 |
Chg. / Chg.(%) | 0.410 / +0.94% |
Bid | 44.180 |
Ask | 44.330 |
Open | 43.770 |
Previous Close | 43.770 |
High | 44.680 |
Low | 43.680 |
Volume [EUR] | - |
Volume [Units] | |
Price fixings | 1714 |
ISIN | NL0012169213 |
Security | QIA |
Exchange | Lang & Schwarz |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Xetra | 44.260 | ![]() |
491,036 |
Cboe Europe .. | 44.39 | ![]() |
114,782 |
Turquoise | 44.51 | ![]() |
59,781 |
TradeGate | 44.18 | ![]() |
17,214 |
Frankfurt | 44.3300 | ![]() |
12,056 |
London Inter.. | 44.51 | ![]() |
9,078 |
Stuttgart | 44.180 | ![]() |
3,156 |
Cboe Europe .. | 44.18 | ![]() |
1,893 |
gettex | 44.320 | ![]() |
660 |
Cboe Europe .. | 44.20 | ![]() |
547 |
Hannover | 44.240 | ![]() |
103 |
Vienna Globa.. | 44.40 | ![]() |
0 |
München | 44.110 | ![]() |
0 |
Düsseldorf | 44.180 | ![]() |
0 |
Hamburg | 44.080 | ![]() |
0 |
Berlin | 44.060 | ![]() |
0 |
Lang & Schwa.. | 44.180 | ![]() |
|
NYSE | 53.20 | ![]() |
558,329 |
Cboe US | 53.11 | ![]() |
11,857 |
IEX | 53.19 | ![]() |
5,873 |
EUREX | Options |
News
- OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics
12/09/2020 / 13:30 - GlobeNewswire - HTG Molecular Diagnostics Reports Third Quarter 2020 Results
11/10/2020 / 22:01 - GlobeNewswire - Ellume Secures $30M from National Institutes of Health RADx Initiative to Accelerate Development of Rapid COVID-19 Diagnostics
10/06/2020 / 21:30 - GlobeNewswire - Thermo Fisher's acquisition of Qiagen fails
08/13/2020 / 13:48 - TeleTrader - HTG Molecular Diagnostics Reports Second Quarter 2020 Results
08/11/2020 / 22:01 - GlobeNewswire